Intel stock whipsaws ahead of CES Panther Lake debut as 18A chipmaking bet comes due
6 January 2026
2 mins read

Intel stock whipsaws ahead of CES Panther Lake debut as 18A chipmaking bet comes due

New York, January 5, 2026, 17:49 ET — After-hours

  • Intel closed down 0.03% at $39.37 after a sharp intraday reversal.
  • Investors are focused on Intel’s CES update on Panther Lake, its first high-volume chip on the 18A process.
  • Melius Research upgraded Intel to “buy” and lifted its price target to $50, according to a media report.

Intel shares finished nearly flat on Monday and were little changed after the bell, as traders positioned ahead of the company’s CES presentation later in the evening. The stock closed down 0.03% at $39.37. 1

The stakes are tied to Panther Lake, Intel’s next-generation laptop processor aimed at artificial intelligence workloads, which the company is set to detail at CES in Las Vegas. Panther Lake is the first high-volume product built on Intel’s “18A” process — its next chipmaking technology — after the prior Lunar Lake generation relied heavily on Taiwan Semiconductor Manufacturing Co; Intel has also been working to lift manufacturing “yield,” or the share of usable chips per silicon wafer. 2

CES runs January 6-9, and the early-week press events often move PC and chip stocks before the show floor opens. For Intel, any clarity on timing and production ramps matters now because 18A sits at the center of its plan to bring advanced manufacturing back in-house and expand its foundry business — making chips for outside customers. 3

The Intel event is scheduled for 6 p.m. ET and will be led by Jim Johnson, a senior vice president who runs the company’s PC group, Engadget reported. Investors are likely to watch for updates on manufacturing progress and how quickly new designs show up in laptops from major PC makers. 4

Intel stock traded like a headline-driven name on Monday. Shares opened at $41.68, ran up to $42.01, then slid to an intraday low of $39.28 before settling near $39; about 96 million shares changed hands.

A bullish analyst call also fed early optimism. Melius Research analyst Ben Reitzes upgraded Intel to “buy” and set a $50 price target, and he argued the AI trade can persist if chipmakers “deliver AI productivity and usage soars,” Barron’s reported. 5

But the downside scenario is straightforward: if Intel cannot ramp 18A smoothly or if performance claims land softly against competitors’ launches, confidence can fade fast. Any hint that Intel must lean more on outside manufacturing again would pressure the turnaround narrative.

Beyond CES, the next fundamental checkpoint is quarterly results, but Intel’s investor-relations calendar does not currently list an earnings date. Nasdaq’s earnings calendar estimates a late-January report, but the company has not confirmed timing.

Technically, Monday’s $42 high and the retreat back toward $39 leave traders with fresh reference points. A move back through $42 would signal renewed momentum, while slipping under the day’s lows would test how much of the CES optimism is already priced in.

The next catalyst is Intel’s CES presentation at 6 p.m. ET, where investors will look for concrete details on Panther Lake’s rollout and the pace of Intel’s 18A manufacturing ramp.

Stock Market Today

Lucid stock jumps 14% as Dow tops 50,000 — what LCID investors watch next week

Lucid stock jumps 14% as Dow tops 50,000 — what LCID investors watch next week

7 February 2026
Lucid Group shares jumped 14% to $10.86 at Friday’s close, recovering from an 8% drop the previous day. The move followed a broad Wall Street rally that lifted high-volatility stocks. Lucid reported fourth-quarter deliveries of 5,345 vehicles and full-year deliveries of 15,841. Investors await Lucid’s Feb. 24 results for updates on cash and demand.
Coterra stock slips as natural gas prices slide 5% — what traders watch next
Previous Story

Coterra stock slips as natural gas prices slide 5% — what traders watch next

Eli Lilly stock slides as Novo’s Wegovy pill hits U.S. market and revives price pressure fears
Next Story

Eli Lilly stock slides as Novo’s Wegovy pill hits U.S. market and revives price pressure fears

Go toTop